[1] 覃祥城,曾景奇,王凡,等.中药促进牵张成骨的研究进展[J].广州中医药大学学报, 2020, 37(2): 382-385. [2] Inada N, Ohata T, Maruno H, et al. Optimal timing for intermittent administration of parathyroid hormone (1-34) for distraction osteogenesis in rabbits [J]. J Orthop Surg Res, 2022, 17(1): 130. [3] Zhang W, Wang N, Yang M, et al. Periosteum and development of the tissue-engineered periosteum for guided bone regeneration [J]. J Orthop Translat, 2022, 33: 41-54. [4] Zhao H, Jia Y, Wang F, et al. Cobalt-doped mesoporous silica coated magnetic nanoparticles promoting accelerated bone healing in distraction osteogenesis [J]. Int J Nanomedicine, 2023, 18: 2359-2370. [5] Chen T, Wang Y, Hao Z, et al. Parathyroid hormone and its related peptides in bone metabolism [J]. Biochem Pharmacol, 2021, 192: 114669. [6] 李永頔,朱鹏娜,王冬香,等.骨保护素/核因子κB受体活化因子配体在甲状旁腺激素调控下颌骨牵张成骨中的表达效应[J].华西口腔医学杂志,2016,34(3): 234-238. [7] Ai-Aql ZS, Alagl AS, Graves DT, et al. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis [J]. J Dent Res, 2008, 87(2): 107-118. [8] Zweifler LE, Sinder BP, Stephan C, et al. Parathyroid hormone and trabectedin have differing effects on macrophages and stress fracture repair [J]. Bone, 2024, 179: 116983. [9] 袁红梅,万敬员,张力.促炎症消退新介质:消退素与保护素[J]. 生命科学,2012,24(1): 54-57. [10] Xiang SY, Ye Y, Yang Q, et al. RvD1 accelerates the resolution of inflammation by promoting apoptosis of the recruited macrophages via the ALX/FasL-FasR/caspase-3 signaling pathway [J]. Cell Death Discov, 2021, 7(1): 339. [11] Gao J, Su Y, Wang Z. Lung inflammation resolution by RvD1 and RvD2 in a receptor-dependent manner [J]. Pharmaceutics, 2023, 15(5):1527. [12] 刘音辰.特异性促炎症消退介质在牙周炎中的研究进展[J].华西口腔医学杂志,2021,39(1): 94-98. [13] Sordi R, Chiazza F, Collotta D, et al. Resolvin D1 attenuates the organ injury associated with experimental hemorrhagic shock [J]. Ann Surg, 2021, 273(5): 1012-1021. [14] McCauley LK, Dalli J, Koh AJ, et al. Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2 [J]. J Immunol, 2014, 193(1): 26-29. [15] Tang ZL, Zhang WJ, Wang DX, et al. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone [J]. J Oral Maxillofac Surg, 2014, 72(2): 419-430. [16] Ohata T, Maruno H, Ichimura S. Changes over time in callus formation caused by intermittently administering PTH in rabbit distraction osteogenesis models [J]. J Orthop Surg Res, 2015, 10: 88. [17] Wang SP, Chen YJ, Hsu CE, et al. Intermittent parathyroid hormone treatment affects the bone structural parameters and mechanical strength of the femoral neck after ovariectomy-induced osteoporosis in rats [J]. Biomed Eng Online, 2022, 21(1): 6. [18] Yamashita J, McCauley LK. Effects of intermittent administration of parathyroid hormone and parathyroid hormone-related protein on fracture healing: A narrative review of animal and human studies [J]. JBMR Plus, 2019, 3(12): e10250. [19] Wagner F, Vach W, Augat P, et al. Daily subcutaneous Teriparatide injection increased bone mineral density of newly formed bone after tibia distraction osteogenesis, a randomized study [J]. Injury, 2019, 50(8): 1478-1482. [20] Shen H, Jiang W, Yu Y, et al. microRNA-146a mediates distraction osteogenesis via bone mesenchymal stem cell inflammatory response [J]. Acta Histochem, 2022, 124(6): 151913. [21] Zhang J, Chen J, Jiang Q, et al. Resolvin D1 attenuates inflammation and pelvic pain associated with EAP by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway [J]. J Inflamm Res, 2023, 16: 3365-3379. [22] Xu B, Li M, Cheng T, et al. Resolvin D1 protects against sepsis-associated encephalopathy in mice by inhibiting neuro-inflammation induced by microglia [J]. Am J Transl Res, 2022, 14(9): 6737-6750. [23] Pinto N, Klein Y, David E, et al. Resolvin D1 improves allograft osteointegration and directly enhances osteoblasts differentiation [J]. Front Immunol, 2023, 14: 1086930. [24] Benabdoun HA, Kulbay M, Rondon EP, et al. In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis [J]. Arthritis Res Ther, 2019, 21(1): 72. [25] Runtsch MC, Angiari S, Hooftman A, et al. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages [J]. Cell Metab, 2022, 34(3): 487-501.e8. [26] Muñoz J, Akhavan NS, Mullins AP, et al. Macrophage polarization and osteoporosis: A review [J]. Nutrients, 2020, 12(10):2999. [27] Chazaud B. Inflammation and skeletal muscle regeneration: Leave it to the macrophages! [J]. Trends Immunol, 2020, 41(6): 481-492. [28] 聂张玲,包崇云.巨噬细胞影响骨形成机制的研究进展[J].口腔医学研究,2021,37(11): 966-969. |